Earlier this month, Kaival Brands (OTCQB: KAVL), the exclusive global distributor of products manufactured by Bidi Vapor LLC˜ announced the expectations for FY 2021 are to exceed a staggering $400 Million in revenues. These are NASDAQ caliber company numbers and what makes it even more impressive, the company is less than a year old. Kaival Brands commenced business… Continue reading 400 Million Reasons Kaival Brands’ “Bidi Stick” is a Hidden Juul
GEORGIA VOTE Could Tip Scales in Cannabis Legalization – TOP MJ STOCKS TO WATCH
A record 3 million Georgia voters cast their ballots before early voting ended for the U.S. Senate runoffs, setting up a showdown that will be decided on election day on Tuesday, January 5th, 2021. The race is particularly important in regard to which party controls the U.S. Senate and many agendas Democratic leadership may wish… Continue reading GEORGIA VOTE Could Tip Scales in Cannabis Legalization – TOP MJ STOCKS TO WATCH
Is There Hope for Top Players in Canada’s CBD Oil Market?
What a difference two years can make. In the months leading up to cannabis legalization, speculators were promoting a green gold rush to the masses. Rosy predictions foretold the mass abandonment of the black market and the emergence of new users. Then October 2018 came. While feelings of jubilation (and clouds of skunky smoke) were… Continue reading Is There Hope for Top Players in Canada’s CBD Oil Market?
U.S. stock futures rise following Friday’s omicron-sparked selloff
The big news circulating this week was of Atea Pharmaceuticals’ (NASDAQ: AVIR) COVID-19 antiviral clinical trial failure, which instantly plummeted the stock by about 65% as investors reevaluated whether the company had any special sauce at all. AT-527, the company’s COVID-19 oral antiviral, was by far its lead asset and now the company will have… Continue reading U.S. stock futures rise following Friday’s omicron-sparked selloff
Here’s what the Black Friday carnage may mean for the stock market’s trade Monday, analysts say
Todos Medical (OTCMKTS: TOMDF) today announced excellent Phase 1/2 results that appear to take dying from COVID-19 off the table. In a small clinical trial of 32 patients the company tested Tollovir in hospitalized patients. Although the treated group was small Tollovir performed very well and had zero deaths in the treated cohort versus 5… Continue reading Here’s what the Black Friday carnage may mean for the stock market’s trade Monday, analysts say
The U.S. stock market suffers ugly Black Friday selloff. Here are the biggest losers (and the winners).
Globe Net Wireless Corp. (OTCMKTS: GNTW) isn’t your typical reverse merger deal because the acquiring asset has a solid base of revenue. The company reversing into GNTW is called Stemtech Corp and it is a direct-to-consumer-based business with nutraceutical products capable of releasing the number of adult stem cells circulating in our system allowing us… Continue reading The U.S. stock market suffers ugly Black Friday selloff. Here are the biggest losers (and the winners).
Oil prices claw back some of Friday’s rout, as OPEC reportedly set to delay technical meetings
Shares of Moderna (NASDAQ: MRNA) recently spiked over $400, giving the mRNA vaccine maker a market cap of about $200 billion, greater than big pharma behemoth Merck (NYSE: MRK), for a few days. Investors must have bid up the stock anticipating the need for COVID-19 vaccine booster shots. However, that thesis is extremely flawed and… Continue reading Oil prices claw back some of Friday’s rout, as OPEC reportedly set to delay technical meetings
Why the new tax law caused a ‘perfect storm’ for Roth IRA conversions
CytoDyn Inc. (OTCMKTS: CYDY) has been going through a massive consolidation since March 30, 2021 after they announced a statistically significant 82% reduction in mortality at day 14. The great news fell on deaf ears at the FDA who instead of issuing an EUA lashed back at shareholders who were badgering them for approval with… Continue reading Why the new tax law caused a ‘perfect storm’ for Roth IRA conversions